Lataa...
Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
BACKGROUND: Evidence remains contradictory regarding second-line therapy in patients with Kawasaki disease (KD) refractory to initial intravenous immunoglobulin (IVIg). The objective of this study aims to evaluate the efficacy and safety of three treatments [i.e. a second IVIg infusion, methylpredni...
Tallennettuna:
| Julkaisussa: | Pediatr Rheumatol Online J |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6882052/ https://ncbi.nlm.nih.gov/pubmed/31775898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-019-0380-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|